Literature DB >> 27559138

Hypoxia and hypercapnia inhibit hypothalamic orexin neurons in rats.

Olga Dergacheva1, Akihiro Yamanaka2, Alan R Schwartz3, Vsevolod Y Polotsky3, David Mendelowitz4.   

Abstract

Evidence of impaired function of orexin neurons has been found in individuals with cardiorespiratory disorders, such as obstructive sleep apnea (OSA) and sudden infant death syndrome (SIDS), but the mechanisms responsible are unknown. Individuals with OSA and SIDS experience repetitive breathing cessations and/or rebreathing of expired air, resulting in hypoxia/hypercapnia (H/H). In this study, we examined the responses of fluorescently identified rat orexin neurons in the lateral hypothalamus to acute H/H to test if and how these neurons alter their activity and function during this challenge. Experiments were conducted in an in vitro slice preparation using voltage-clamp and current-clamp configurations. H/H (10 min) induced hyperpolarization, accompanied by rapid depression, and finally, cessation of firing activity in orexin neurons. Hypoxia alone had similar but less potent effects. H/H did not alter the frequency of inhibitory glycinergic postsynaptic currents. The frequency of GABAergic currents was diminished but only at 8-10 min of H/H. In contrast, the frequency of excitatory glutamatergic postsynaptic events was diminished as early as 2-4 min of H/H. In the presence of glutamatergic receptor blockers, the inhibitory effects of H/H on the firing activity and membrane potential of orexin neurons persisted but to a lesser extent. In conclusion, both direct alteration of postsynaptic membrane properties and diminished glutamatergic neurotransmission likely contribute to the inhibition of orexin neurons by H/H. These mechanisms could be responsible for the decreased function of orexin in individuals at risk for OSA and SIDS.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  hypercapnia; hypoxia; obstructive apnea; orexin

Mesh:

Substances:

Year:  2016        PMID: 27559138      PMCID: PMC5102318          DOI: 10.1152/jn.00196.2016

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  62 in total

1.  Release of hypocretin (orexin) during waking and sleep states.

Authors:  Lyudmila I Kiyashchenko; Boris Y Mileykovskiy; Nigel Maidment; Hoa A Lam; Ming-Fung Wu; Joshi John; John Peever; Jerome M Siegel
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

2.  Plasma orexin-A-like immunoreactivity in patients with sleep apnea hypopnea syndrome.

Authors:  Tsuguo Nishijima; Shigeru Sakurai; Zenei Arihara; Kazuhiro Takahashi
Journal:  Peptides       Date:  2003-03       Impact factor: 3.750

3.  Expression of the M3 Muscarinic Receptor on Orexin Neurons that Project to the Rostral Ventrolateral Medulla.

Authors:  Yu-Wen E Dai; Yen-Hsien Lee; Jennifer Y S Chen; Yen-Kuang Lin; Ling-Ling Hwang
Journal:  Anat Rec (Hoboken)       Date:  2016-03-09       Impact factor: 2.064

4.  Chronic intermittent hypoxia alters neurotransmission from lateral paragigantocellular nucleus to parasympathetic cardiac neurons in the brain stem.

Authors:  Olga Dergacheva
Journal:  J Neurophysiol       Date:  2014-10-15       Impact factor: 2.714

Review 5.  Respiration and autonomic regulation and orexin.

Authors:  Eugene Nattie; Aihua Li
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

Review 6.  Stress, arousal, and sleep.

Authors:  Larry D Sanford; Deborah Suchecki; Peter Meerlo
Journal:  Curr Top Behav Neurosci       Date:  2015

7.  Orexinergic modulation of GABAergic neurotransmission to cardiac vagal neurons in the brain stem nucleus ambiguus changes during development.

Authors:  O Dergacheva; R Bateman; P Byrne; D Mendelowitz
Journal:  Neuroscience       Date:  2012-02-21       Impact factor: 3.590

8.  Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin.

Authors:  A N van den Pol; X B Gao; K Obrietan; T S Kilduff; A B Belousov
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

9.  Cumulative effects of repetitive intermittent hypercapnic hypoxia on orexin in the developing piglet hypothalamus.

Authors:  Man K Du; Nicholas J Hunt; Karen A Waters; Rita Machaalani
Journal:  Int J Dev Neurosci       Date:  2015-11-06       Impact factor: 2.457

10.  Cell type–specific channelrhodopsin-2 transgenic mice for optogenetic dissection of neural circuitry function.

Authors:  Shengli Zhao; Jonathan T Ting; Hisham E Atallah; Li Qiu; Jie Tan; Bernd Gloss; George J Augustine; Karl Deisseroth; Minmin Luo; Ann M Graybiel; Guoping Feng
Journal:  Nat Methods       Date:  2011-09       Impact factor: 28.547

View more
  8 in total

1.  Combined hypoxia and hypercapnia, but not hypoxia alone, suppresses neurotransmission from orexin to hypothalamic paraventricular spinally-projecting neurons in weanling rats.

Authors:  Olga Dergacheva; David Mendelowitz
Journal:  Brain Res       Date:  2017-11-21       Impact factor: 3.252

2.  Orexin facilitates the ventilatory and behavioral responses of rats to hypoxia.

Authors:  Richard L Spinieli; Ruwaida Ben Musa; Jennifer Cornelius-Green; Eileen M Hasser; Kevin J Cummings
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2022-04-05       Impact factor: 3.210

3.  Direct projections from hypothalamic orexin neurons to brainstem cardiac vagal neurons.

Authors:  Olga Dergacheva; Akihiro Yamanaka; Alan R Schwartz; Vsevolod Y Polotsky; David Mendelowitz
Journal:  Neuroscience       Date:  2016-09-28       Impact factor: 3.590

Review 4.  Definition and Diagnosis of the Trigeminocardiac Reflex: A Grounded Theory Approach for an Update.

Authors:  Cyrill Meuwly; Tumul Chowdhury; Nora Sandu; Eugene Golanov; Paul Erne; Thomas Rosemann; Bernhard Schaller
Journal:  Front Neurol       Date:  2017-10-09       Impact factor: 4.003

Review 5.  Obstructive sleep apnoea and Alzheimer's disease: In search of shared pathomechanisms.

Authors:  D Polsek; N Gildeh; D Cash; R Winsky-Sommerer; S C R Williams; F Turkheimer; G D Leschziner; M J Morrell; I Rosenzweig
Journal:  Neurosci Biobehav Rev       Date:  2017-12-07       Impact factor: 8.989

6.  Effectiveness of Pharmacological Agents and Validation of Diagnostic Scales for the Management of Paroxysmal Sympathetic Hyperactivity in Hispanics.

Authors:  Alaa K Abdelhakiem; Annelyn Torres-Reveron; Juan M Padilla
Journal:  Front Neurol       Date:  2020-11-16       Impact factor: 4.003

7.  Sleep Apnea-Specific Hypoxic Burden and Not the Sleepy Phenotype as a Novel Measure of Cardiovascular and Mortality Risk in a Clinical Cohort.

Authors:  Reena Mehra; Ali Azarbarzin
Journal:  Am J Respir Crit Care Med       Date:  2022-01-01       Impact factor: 30.528

8.  Body composition and obstructive sleep apnoea assessment in adult patients with Prader-Willi syndrome: a case control study.

Authors:  G Pugliese; L Barrea; A Sanduzzi Zamparelli; G de Alteriis; D Laudisio; G Muscogiuri; A Canora; M Bocchino; A Colao; S Savastano
Journal:  J Endocrinol Invest       Date:  2022-06-20       Impact factor: 5.467

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.